NCI - Surgery Branch

Bethesda, Maryland 20892-1201

0 studies enrolling now · 8 studies all time

What they study most

Adrenocortical Carcinoma, Breast Cancer, Colorectal Cancer, Gastrointestinal Cancer, Kidney Cancer, Liver Cancer, Melanoma (Skin), Non-melanomatous Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific

Studies at this site

• MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery — Completed
• Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma — Completed
• Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma — Completed
• LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery — Completed
• Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer — Completed
• Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma — Stopped early
• TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors — Completed
• Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma — Completed